Concepedia

Publication | Open Access

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer

DOIFull Paper Access

76

Citations

22

References

2016

Year

Neeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, Nancy Lewis, Michaela J. Higgins, Kari B. Wisinski, Ahmad Awada, Michela Maur, Mark N. Stein, Andy Hwang,
The Oncologist

Abstract

Treatment with LFA102 was safe and well tolerated, but did not show antitumor activity as monotherapy at the doses tested.

References

YearCitations

Page 1